Pharming has not registered any new issuance of securities in connection with this filing. The ordinary shares of Pharming continue to be listed and traded on Euronext Amsterdam.
Pharming is a global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs. NautaDutilh has assisted Pharming on many transactions over the last years, including the EUR 125 mio convertible bonds issue in January 2019.
NautaDutilh acted as Dutch counsel alongside Cooley LLP. The NautaDutilh team, led by Petra Zijp and Paul van der Bijl, consisted of Sabrina Legerstee, Annefleur van Oel and Tessa van Berkum (Capital Markets), Koen Biesma and Marloes van der Laan (Corporate Notarial), Nina Kielman and Alissia Sudibyo (Tax).